TH Healthcare & Life Sciences Monthly Top Global M&A Market Update provides a snapshot of key transactions, deal activity and trends shaping the global healthcare and life sciences M&A market.
In our July 2026 edition, we tracked 22 healthcare and life sciences transactions across Healthcare IT, Digital Health, Drug Discovery & Biotech, Healthcare Services, and Medtech.
Key Insights
- Healthcare IT Leads Activity: Healthcare IT accounted for 13 of the 22 transactions tracked in July, representing 59% of total deal activity.
- Digital Health Momentum: Digital Health / Telehealth recorded 5 transactions, with activity spanning virtual behavioural health, health data interoperability, fertility decision support, teleconsultation, patient monitoring, and patient engagement platforms.
- Continued Consolidation: Strategic and sponsor-backed buyers continued to pursue bolt-on acquisitions, platform expansions, carve-outs, and vertical consolidation across the healthcare ecosystem.
- Diverse Investment Activity: Private equity activity remained visible across Healthcare IT, Drug Discovery / Biotech, Healthcare Services, and Digital Health, alongside continued corporate M&A.
Why Download This Newsletter?
Gain a concise view of the latest global Healthcare & Life Sciences M&A activity, including key transactions, active sub-segments, investor participation and emerging consolidation themes, with valuable insights for healthcare and life sciences executives, investors and industry leaders tracking deal activity, market developments and strategic opportunities.